U.S. markets close in 4 hours 11 minutes

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.32-0.36 (-6.43%)
As of 11:49AM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/22/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
1.12B628.51M802.88M594.23M766.44M362.24M
Enterprise Value 3
959.74M434.42M581.73M444.85M589.48M150.59M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
10.916.668.106.1514.867.37
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
10.5023.8838.7233.4813.1411.34
Enterprise Value/EBITDA 6
-20.98-26.85-32.91-19.4853.87-9.06

Trading Information

Stock Price History

Beta (5Y Monthly) 1.79
52-Week Change 367.55%
S&P500 52-Week Change 313.92%
52 Week High 37.07
52 Week Low 31.95
50-Day Moving Average 35.50
200-Day Moving Average 34.56

Share Statistics

Avg Vol (3 month) 32.77M
Avg Vol (10 day) 32.35M
Shares Outstanding 5187.53M
Float 175.76M
% Held by Insiders 10.56%
% Held by Institutions 176.45%
Shares Short (Oct 29, 2020) 418.72M
Short Ratio (Oct 29, 2020) 45.2
Short % of Float (Oct 29, 2020) 411.10%
Short % of Shares Outstanding (Oct 29, 2020) 49.98%
Shares Short (prior month Sep 29, 2020) 417.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -77.65%
Operating Margin (ttm)-52.94%

Management Effectiveness

Return on Assets (ttm)-12.04%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)91.36M
Revenue Per Share (ttm)0.55
Quarterly Revenue Growth (yoy)37.00%
Gross Profit (ttm)-32.25M
EBITDA -46.05M
Net Income Avi to Common (ttm)-70.95M
Diluted EPS (ttm)-0.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)188.22M
Total Cash Per Share (mrq)1
Total Debt (mrq)24.67M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.20
Book Value Per Share (mrq)-0.25

Cash Flow Statement

Operating Cash Flow (ttm)-119.71M
Levered Free Cash Flow (ttm)-30.09M